Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
455.09
341.00
192.08
192.56
323.91
431.99
375.30
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
455.09
341.00
192.08
192.56
323.91
431.99
375.30
Raw Material Cost
245.28
199.53
137.91
111.85
99.48
96.67
82.11
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
162.09
145.56
141.71
114.80
98.02
101.98
84.38
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
5.83
3.93
2.72
2.36
0.15
0.16
0.17
Selling and Distribution Expenses
143.56
126.37
131.59
118.79
127.21
161.95
137.72
Other Expenses
-7.36
-6.39
-1.39
0.15
-1.18
-2.97
-2.90
Total Expenditure (Excl Depreciation)
483.16
411.48
400.02
349.28
313.03
331.10
275.43
Operating Profit (PBDIT) excl Other Income
-28.1
-70.5
-207.89999999999998
-156.7
10.9
100.9
99.9
Other Income
33.81
15.49
8.52
7.37
19.25
7.94
3.93
Operating Profit (PBDIT)
91.22
28.38
-126.65
-77.84
75.07
142.72
117.67
Interest
5.83
3.93
2.72
2.36
0.15
0.16
0.17
Exceptional Items
0.00
0.00
0.00
0.18
0.13
0.00
0.00
Gross Profit (PBDT)
209.82
141.47
54.17
80.71
224.44
335.33
293.19
Depreciation
102.55
87.36
87.27
80.89
46.21
34.58
14.80
Profit Before Tax
-17.16
-62.91
-216.64
-160.91
28.84
107.97
102.70
Tax
-13.27
-24.46
-48.03
-31.80
6.35
17.94
13.51
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
1.50
-39.63
-162.38
-130.77
22.49
90.04
89.19
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
1.50
-39.63
-162.38
-130.77
22.49
90.04
89.19
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-5.39
-3.77
-10.93
-0.53
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-3.89
-43.40
-173.31
-131.30
22.49
90.04
89.19
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
866.89
819.96
847.08
927.84
1,077.87
1,098.51
701.28
Earnings per share (EPS)
0.0
-0.1
-0.4
-0.32
0.05
0.22
0.22
Diluted Earnings per share
0.0
-0.1
-0.4
-0.32
0.05
0.22
0.22
Operating Profit Margin (Excl OI)
-9.92%
-21.84%
-115.81%
-86.26%
2.97%
23.19%
26.36%
Gross Profit Margin
18.76%
7.17%
-67.35%
-41.56%
23.17%
33.0%
31.31%
PAT Margin
0.33%
-11.62%
-84.54%
-67.91%
6.94%
20.84%
23.77%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is 33.46% vs 77.51% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is 91.01% vs 74.96% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is 344.96% vs 109.54% in Dec 2023
Interest
YoY Growth in year ended Dec 2024 is 48.72% vs 44.44% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has improved from Dec 2023
Compare Annual Results Of Sino Medical Sciences Technology, Inc. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
455.09
0
455.09
Other Operating Income
0.00
0.00
0.00
Total Operating income
455.09
0
455.09
Raw Material Cost
245.28
0
245.28
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
162.09
0
162.09
Power Cost
0
0
0.00
Manufacturing Expenses
5.83
0
5.83
Selling and Distribution Expenses
143.56
0
143.56
Other Expenses
-7.36
0.00
-7.36
Total Expenditure (Excl Depreciation)
483.16
0
483.16
Operating Profit (PBDIT) excl Other Income
-28.07
0.00
-28.07
Other Income
33.81
0
33.81
Operating Profit (PBDIT)
91.22
0
91.22
Interest
5.83
0
5.83
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
209.82
0
209.82
Depreciation
102.55
0
102.55
Profit Before Tax
-17.16
0
-17.16
Tax
-13.27
0
-13.27
Provisions and contingencies
0
0
0.00
Profit After Tax
1.50
0
1.50
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
1.50
0
1.50
Share in Profit of Associates
0
0
0.00
Minority Interest
-5.39
0
-5.39
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-3.89
0
-3.89
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
866.89
0
866.89
Earnings per share (EPS)
0.00
0
0.00
Diluted Earnings per share
0.00
0
0.00
Operating Profit Margin (Excl OI)
-9.92%
0%
0.00
-9.92%
Gross Profit Margin
18.76%
0%
0.00
18.76%
PAT Margin
0.33%
0%
0.00
0.33%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 45.51 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 33.46% vs 77.51% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit -0.39 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 91.01% vs 74.96% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 5.74 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 344.96% vs 109.54% in Dec 2023
Annual - Interest
Interest 0.58 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 48.72% vs 44.44% in Dec 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -9.92%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has improved from Dec 2023






